Evidence map›Paper›PMID 28594891›Full record

ArticlePLoS neglected tropical diseases2017

Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.

Lucy A Parker, John Rumunu, Christine Jamet, Yona Kenyi, Richard Laku Lino, Joseph F Wamala, Allan M Mpairwe, Vincent Muller, Augusto E Llosa, Florent Uzzeni and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Implementation of targeted cholera response activities, Cameroon.Bulletin of the World Health Organization · 2023
    Article
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Lucy A ParkerMédecins Sans Frontières, Geneva, Switzerland.
John RumunuRepublic of South Sudan Ministry of Health, Juba, South Sudan.
Christine JametMédecins Sans Frontières, Geneva, Switzerland.
Yona KenyiRepublic of South Sudan Ministry of Health, Juba, South Sudan.
Richard Laku LinoRepublic of South Sudan Ministry of Health, Juba, South Sudan.
Joseph F WamalaWorld Health Organization, Juba, South Sudan.
Allan M MpairweWorld Health Organization, Juba, South Sudan.
Vincent MullerMédecins Sans Frontières, Geneva, Switzerland.
Augusto E LlosaEpicentre, Paris, France.
Florent UzzeniMédecins Sans Frontières, Geneva, Switzerland.
Francisco J LuqueroEpicentre, Paris, France.
Iza CigleneckiMédecins Sans Frontières, Geneva, Switzerland.
Andrew S AzmanMédecins Sans Frontières, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-8662-9077
Médecins Sans Frontières · CHFederal Ministry of Health · SDJohns Hopkins University · USUniversity of Juba · SSUniversitat de Miguel Hernández d'Elx · ES

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionIn June 2015, a cholera outbreak was declared in Juba, South Sudan. In addition to standard outbreak control measures, oral cholera vaccine (OCV) was proposed. As sufficient doses to cover the at-risk population were unavailable, a campaign using half the standard dosing regimen (one-dose) targeted high-risk neighborhoods and groups including neighbors of suspected cases. Here we report the operational details of this first public health use of a single-dose regimen of OCV and illustrate the feasibility of conducting highly targeted vaccination campaigns in an urban area. METHODOLOGY/PRINCIPAL

findingsNeighborhoods of the city were prioritized for vaccination based on cumulative attack rates, active transmission and local knowledge of known cholera risk factors. OCV was offered to all persons older than 12 months at 20 fixed sites and to select groups, including neighbors of cholera cases after the main campaign ('case-triggered' interventions), through mobile teams. Vaccination coverage was estimated by multi-stage surveys using spatial sampling techniques. 162,377 individuals received a single-dose of OCV in the targeted neighborhoods. In these neighborhoods vaccine coverage was 68.8% (95% Confidence Interval (CI), 64.0-73.7) and was highest among children ages 5-14 years (90.0%, 95% CI 85.7-94.3), with adult men being less likely to be vaccinated than adult women (Relative Risk 0.81, 95% CI: 0.68-0.96). In the case-triggered interventions, each lasting 1-2 days, coverage varied (range: 30-87%) with an average of 51.0% (95% CI 41.7-60.3). CONCLUSIONS/SIGNIFICANCE: Vaccine supply constraints and the complex realities where cholera outbreaks occur may warrant the use of flexible alternative vaccination strategies, including highly-targeted vaccination campaigns and single-dose regimens. We showed that such campaigns are feasible. Additional work is needed to understand how and when to use different strategies to best protect populations against epidemic cholera.

Indexed as

Urban PopulationAdministration, OralAdolescentAdultAgedChildChild, PreschoolCholeraCholera VaccinesDisease OutbreaksFemaleHumansInfantMaleMiddle AgedSudanCholera Vaccines

Identifiers

PMID28594891
PMCPMC5478158
OpenAlexW2622840526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.